Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fate Therapeutics Inc (NASDAQ:FATE)

1.98
Delayed Data
As of Jul 28
 +0.11 / +5.88%
Today’s Change
1.46
Today|||52-Week Range
8.05
-41.25%
Year-to-Date
No recent news for Fate Therapeutics Inc.

Today’s Trading

Previous close1.87
Today’s open2.00
Day’s range1.90 - 2.49
Volume3,194,601
Average volume (3 months)269,872
Market cap$54.0M
Dividend yield--
Data as of 3:59pm ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)+7.09%
Earnings growth (this year)-5.30%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales35.33
Price/Book1.41

Competitors

 Today’s
change
Today’s
% change
CRMDCorMedix Inc-0.04-2.67%
CYTRCytRx Corp+0.02+2.85%
KMPHKemPharm Inc+0.03+0.75%
VSTMVerastem Inc+0.18+13.85%
Data as of 4:01pm ET, 07/28/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$2.4M
Annual profit (last year)-$30.0M
Net profit margin-1,233.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
J. Scott Wolchko
Chief Scientific Officer
Daniel D. Shoemaker
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs